Indication
Hereditary coproporphyria
Hereditary coproporphyria is a rare autosomal dominant acute hepatic porphyria caused by mutations in the *CPOX* gene, which leads to a deficiency in the mitochondrial enzyme coproporphyrinogen-III oxidase. Read more about Hereditary coproporphyria
2 drugs 2 manufacturers
Drugs that treat it
Common Hereditary coproporphyria therapies.
PANHEMATIN (hemin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHereditary coproporphyria is a rare autosomal dominant acute hepatic porphyria caused by mutations in the *CPOX* gene, which leads to a deficiency in the mitochondrial enzyme coproporphyrinogen-III oxidase.
This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the pathologic accumulation and excretion of porphyrin precursors—such as porphobilinogen—and coproporphyrin III.
Clinically, it affects the nervous system and integumentary system, typically presenting with episodic, life-threatening neurovisceral attacks characterized by severe abdominal pain, autonomic dysfunction, motor neuropathies, and psychiatric disturbances, frequently precipitated by porphyrogenic drugs, fasting, or hormonal shifts.
Unlike most other acute porphyrias, a subset of affected individuals also exhibits cutaneous photosensitivity, presenting with skin fragility, erythema, and bullous lesions on sun-exposed areas.
- nih.gov
Hereditary coproporphyria is a rare autosomal dominant acute hepatic porphyria caused by mutations in the *CPOX* gene, which leads to a deficiency in the mitochondrial enzyme coproporphyrinogen-III oxidase This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the pathologic accumulation and excretion of porphyrin precursors—such as porphobilinogen—and coproporphyrin III Clinically, it affects the nervous system and integumentary system, typically presenting with episodic, li...
- nih.gov
Hereditary coproporphyria is a rare autosomal dominant acute hepatic porphyria caused by mutations in the *CPOX* gene, which leads to a deficiency in the mitochondrial enzyme coproporphyrinogen-III oxidase
- porphyriafoundation.org
This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the pathologic accumulation and excretion of porphyrin precursors—such as porphobilinogen—and coproporphyrin III Clinically, it affects the nervous system and integumentary system, typically presenting with episodic, life-threatening neurovisceral attacks characterized by severe abdominal pain, autonomic dysfunction, motor neuropathies, and psychiatric disturbances, frequently precipitated by porphyrogenic drugs, fasting,...
- nih.gov
This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the pathologic accumulation and excretion of porphyrin precursors—such as porphobilinogen—and coproporphyrin III
- nih.gov
Clinically, it affects the nervous system and integumentary system, typically presenting with episodic, life-threatening neurovisceral attacks characterized by severe abdominal pain, autonomic dysfunction, motor neuropathies, and psychiatric disturbances, frequently precipitated by porphyrogenic drugs, fasting, or hormonal shifts Unlike most other acute porphyrias, a subset of affected individuals also exhibits cutaneous photosensitivity, presenting with skin fragility, erythema, and bullous les...
- medlineplus.gov
Unlike most other acute porphyrias, a subset of affected individuals also exhibits cutaneous photosensitivity, presenting with skin fragility, erythema, and bullous lesions on sun-exposed areas
Personalize your experience
Follow Hereditary coproporphyria and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.